-
EGF-Driven Migration Without EMT in A549 Cells
2026-08-12
The reference study shows that EGF stimulates migration of A549 lung adenocarcinoma cells without inducing the epithelial–mesenchymal transition or increasing invasion. By comparing EGF, TGFβ, and combined treatment with imaging, functional, molecular, and proteomic assays, the authors distinguish motility from invasive progression and identify different pathway dependencies.
-
Cisplatin (CDDP) Workflow for Cancer Research
2026-08-12
Build more reproducible Cisplatin experiments by linking DNA crosslinking, ROS, apoptosis, and resistance phenotypes in one workflow. This guide translates clinical combination-therapy logic into practical cell-based, mechanistic, and xenograft assay choices while addressing formulation and readout failures.
-
MG-262: Proteasome Inhibition Meets Cell Fate
2026-08-11
MG-262 and Z-Leu-Leu-Leu-B(OH)2 provide a reversible, cell-permeable route to interrogate proteasome-dependent protein quality control. This article connects proteasome inhibition assays with BIRC2/BIRC3 inflammatory signaling, helping researchers distinguish direct proteostasis effects from downstream apoptosis and cell-cycle phenotypes.
-
SP600125 in ROS–MAPK Pain Signaling
2026-08-11
Explore how SP600125, a selective JNK inhibitor, can dissect the ROS–MAPK–Panx3 axis implicated in orofacial neuropathic pain. This article translates recent trigeminal ganglion findings into a rigorous assay strategy while separating evidence from proposed applications.
-
Ionophore Toxicity in Animals: Molecular Insights
2026-08-10
Ekinci, Chłodowska, and Olejnik integrate clinical reports with cellular and molecular evidence to explain how polyether ionophores injure cardiac and skeletal muscle. Their review emphasizes species, age, dose, and tiamulin co-exposure as critical determinants of risk, while identifying disrupted ion homeostasis and mitochondrial oxidative phosphorylation as central mechanistic themes.
-
CHIR-99021 (CT99021) for Reliable Cell Assays
2026-08-09
Learn how CHIR-99021 (CT99021), SKU A3011, can help laboratories separate true changes in cell state from solvent, timing, and assay-readout artifacts. This scenario-based guide covers mechanism, compatibility, protocol control, data interpretation, and practical vendor selection.
-
Lactate–GPR81/FARP1 Drives Insulin-Independent Uptake
2026-08-08
The 2026 Cell Research study identifies L-lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and defines a GPR81–FARP1–RAC1 pathway that promotes GLUT4 translocation. Its genetic, pharmacological, physiological, and human genetic evidence positions lactate sensing as a potential complement to insulin-based control of hyperglycemia.
-
Cell lysis buffer for WB and IP in PCa
2026-08-07
A practical guide to using a non-denaturing lysis system for Western blotting, immunoprecipitation, and co-IP in prostate cancer microenvironment studies. The workflow separates cell-pellet extraction from conditioned-medium assays, helping preserve phosphorylation, protein abundance, and native ANGPTL4–IQGAP1 interactions.
-
Neuroligin 1, Striatal D2 Neurons, and PKC in Repetitive Beh
2026-08-07
This study uncovers how Neuroligin 1 deficiency in striatal D2-expressing medium spiny neurons drives autistic-like repetitive behaviors via PKC overactivation. The findings clarify cellular and molecular links between synaptic adhesion molecules, striatal circuitry, and behavioral phenotypes, informing mechanistic and pharmacological strategies for ASD research.
-
Neuroligin 1 Proteolysis Sustains Social Memory via Cofilin
2026-08-06
Liu et al. (2025) reveal that social interactions trigger α- and γ-secretase-mediated proteolysis of neuroligin 1 in the ventral hippocampus, producing a peptide fragment (NLG1-CTD) essential for maintaining social memory. Their work identifies the NLG1-CTD/cofilin signaling axis as a central mechanism linking synaptic plasticity to memory retention, with implications for neuropsychiatric research.
-
HIV-1 Remodels Nuclear Pores to Enable Infection of Resting
2026-08-06
A recent Nature study reveals that HIV-1 can overcome the intrinsic nuclear import barrier in resting CD4+ T cells by triggering receptor signaling during cell–cell spread, leading to nuclear pore complex remodeling and increased permissivity. These findings challenge longstanding assumptions about T cell activation requirements for infection and provide a framework for investigating host-pathogen interactions at the nuclear envelope.
-
Synergistic Inhibition of EMT in Pancreatic Cancer via CDK4/
2026-08-05
Gu et al. (2025) demonstrate that combined inhibition of CDK4/6 and BET proteins synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth and reverses epithelial-to-mesenchymal transition (EMT) by modulating the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic advance addresses the limitations of CDK4/6 monotherapy and provides a rationale for exploring combinatorial strategies in EMT-focused cancer research.
-
ERAD-Hijacking Chimeras Enable Targeted Membrane Protein Deg
2026-08-05
Song et al. (2026) introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that selectively degrades transmembrane proteins by hijacking the ER-associated degradation pathway. This innovation addresses persistent limitations in targeted protein degradation, offering new experimental flexibility for immunology, oncology, and membrane protein research.
-
Dual-Action Kinase Inhibitors Accelerate p38α Dephosphorylat
2026-08-04
This study uncovers how select kinase inhibitors, including those structurally related to RWJ 67657 (JNJ-3026582), not only block p38α MAP kinase activity but also promote its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings reshape our understanding of kinase inhibitor mechanisms, with significant implications for inflammatory disease research and the development of more selective therapeutic agents.
-
Macrophage-Derived miR-660 in Breast Cancer Metastasis
2026-08-04
The referenced study uncovers how tumor-associated macrophages (TAMs) secrete extracellular vesicles carrying microRNA-660, which promotes breast cancer metastasis by targeting KLHL21 and activating the NF-κB pathway. These insights enhance our understanding of metastatic mechanisms and suggest new avenues for targeted intervention in the tumor microenvironment.